NLRP3 and Parkinson disease: In addition, the therapeutic strategies targeting the NLRP3 inflammasome for PD treatments are discussed in this review, including the application of NLRP3 inflammatory pathway inhibitors, mitochondria-focused treatments, microRNAs, and other therapeutic compounds.